# Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder

> **NCT00457899** · PHASE3 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 234 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorders
- Psychotic Disorders

## Interventions

- **DRUG:** Quetiapine IR (Immediate Release)

## Key facts

- **NCT ID:** NCT00457899
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 234 (ESTIMATED)
- **Why stopped:** Study terminated due to poor recruitment
- **Last updated:** 2007-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00457899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00457899, "Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00457899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*